Authors:
Vredenburg, MR
Ojima, I
Veith, J
Pera, P
Kee, K
Cabral, F
Sharma, A
Kanter, P
Greco, WR
Bernacki, RJ
Citation: Mr. Vredenburg et al., Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance, J NAT CANC, 93(16), 2001, pp. 1234-1245
Citation: Hz. Wang et al., Brain MR imaging in the evaluation of chronic headache in patients withoutother neurologic symptoms, ACAD RADIOL, 8(5), 2001, pp. 405-408
Authors:
Slocum, HK
Parsons, JC
Winslow, EO
Broderick, L
Minderman, H
Toth, K
Greco, WR
Rustum, YM
Citation: Hk. Slocum et al., Time-lapse video reveals immediate heterogeneity and heritable damage among human ileocecal carcinoma HCT-8 cells treated with raltitrexed (ZD1694), CYTOMETRY, 41(4), 2000, pp. 252-260
Authors:
Henderson, BW
Busch, TM
Vaughan, LA
Frawley, NP
Babich, D
Sosa, TA
Zollo, JD
Dee, AS
Cooper, MT
Bellnier, DA
Greco, WR
Oseroff, AR
Citation: Bw. Henderson et al., Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate, CANCER RES, 60(3), 2000, pp. 525-529
Authors:
Faessel, HM
Slocum, HK
Rustum, YM
Greco, WR
Citation: Hm. Faessel et al., Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin-6-yl)-(S)-ethyl]-2,5-thienoylamino-L-glutamic acid (AG2034) - Comparison across sensitive and resistant human tumor cell lines, BIOCH PHARM, 57(5), 1999, pp. 567-577
Authors:
Levasseur, LM
Faessel, H
Slocum, HK
Greco, WR
Citation: Lm. Levasseur et al., Implications for clinical pharmacodynamic studies of the statistical characterization of an in vitro antiproliferation assay, J PHAR BIOP, 26(6), 1998, pp. 717-733